Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.405 USD | -0.44% | +4.68% | +108.73% |
May. 30 | Cantor Fitzgerald Initiates ADC Therapeutics at Overweight Rating | MT |
May. 07 | HC Wainwright Adjusts Price Target on ADC Therapeutics to $8 From $9, Maintains Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+108.73% | 329M | |
+18.15% | 125B | |
+13.37% | 108B | |
-7.45% | 24.21B | |
+2.07% | 22.78B | |
-10.79% | 17.96B | |
-41.74% | 16.43B | |
-13.38% | 16.37B | |
+0.87% | 13.58B | |
+27.84% | 11.66B |
- Stock Market
- Equities
- ADCT Stock
- News ADC Therapeutics SA
- RBC Lifts Price Target on ADC Therapeutics to $8 From $6, 'Encouraged' by Competitive Positioning; Outperform, Speculative Risk Kept